Veru (NASDAQ:VERU - Get Free Report) will likely be posting its Q3 2025 quarterly earnings results before the market opens on Tuesday, August 12th. Analysts expect Veru to post earnings of ($0.06) per share for the quarter.
Veru (NASDAQ:VERU - Get Free Report) last released its quarterly earnings data on Thursday, May 8th. The company reported ($0.50) earnings per share for the quarter, topping the consensus estimate of ($0.60) by $0.10. On average, analysts expect Veru to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Veru Trading Down 0.1%
Shares of Veru stock traded down $0.00 during trading on Friday, hitting $0.37. 2,272,636 shares of the stock were exchanged, compared to its average volume of 1,481,745. The stock has a market capitalization of $54.63 million, a price-to-earnings ratio of -1.55 and a beta of -0.72. The company has a fifty day moving average price of $5.77 and a 200-day moving average price of $5.58. Veru has a 1-year low of $0.36 and a 1-year high of $1.42.
Veru's stock is scheduled to reverse split on the morning of Monday, August 11th. The 1-10 reverse split was announced on Wednesday, August 6th. The number of shares owned by shareholders will be adjusted after the closing bell on Friday, August 8th.
Veru Company Profile
(
Get Free Report)
Veru Inc, a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). Its marketed products comprise FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections.
Recommended Stories
Before you consider Veru, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Veru wasn't on the list.
While Veru currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access